Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)

Introduction

COVID-19 has taken a heavy toll on the health of populations globally.^1-3 Risk factors for severe and fatal disease include male sex, Black or Asian ethnic origin, obesity, deprivation and a range of comorbidities including diabetes mellitus, cardiovascular disease, chronic obstructive pulmonary disease (COPD) and hypertension.^4,5 However, there is growing evidence from population-based studies to suggest that at least some risk factors for developing COVID-19 - irrespective of severity - may be distinct from those which predispose to disease at the most severe end of the spectrum. For example, population-based studies in both the US and the UK have reported that risk of COVID-19 is higher in younger vs. older adults ⁶, a finding supported by serology studies in the UK and Switzerland reporting higher prevalence of antibodies to SARS-CoV-2 in younger vs older adults.^7,8 Again, in contrast to studies reporting that diabetes, heart disease and hypertension are risk factors for severe disease, the presence of pre-existing health conditions has been reported to associate with decreased, rather than increased, risk of SARS-CoV-2 sero-positivity in a population-based study conducted in the UK.⁷

These apparently paradoxical associations are potentially attributable to changes in behaviour in response to the pandemic, whereby people at greater risk of severe disease because of older age or presence of comorbidities may reduce social contact and visits to indoor public places in order to reduce their exposure to SARS-CoV-2. However, to our knowledge, studies to investigate whether behaviours influencing risk of such exposure might partly explain associations between older age, presence of comorbidities and lower risk of developing COVID-19 are lacking. Such studies could potentially shed light on other controversies relating to risk factors for developing COVID-19, such as the extent to which ethnic differences in disease susceptibility can be explained by behavioural, occupational and socio-economic factors,⁹ and whether lifestyle, diet, and use of micronutrient supplements may influence risk of developing COVID-19.^10,11

In order to address this knowledge gap, we established a new longitudinal study (COVIDENCE UK) at the start of the pandemic, with the specific aim of capturing detailed information on a very wide range of potential risk factors for COVID-19. Sufficient incident cases of test-confirmed COVID-19 have now accumulated to allow us to evaluate how a comprehensive panel of demographic, socio-economic, lifestyle, dietary, pharmacological and comorbidity factors relate to the risk of developing COVID-19.

Methods

Results

Of the 17,558 participants who completed the COVIDENCE UK baseline questionnaire on or before 2^nd November 2020, we excluded those who were identified as already having had test-confirmed and/or symptom-defined probable COVID-19 (n=1,613) prior to initiation of the study and those who did not complete at least one monthly follow-up questionnaire (n=854), leaving 15,227 participants eligible for inclusion in this prospective analysis (Figure S1, Supplementary Appendix). Selected baseline characteristics are presented in Table 1. Mean age was 59.4 years (range 16.0 to 94.4 years), 69.8% were female, and 94.9% identified their ethnic origin as White. The geographical distribution of COVIDENCE UK participants aligned closely with that of incident COVID-19 in the UK (Figure S2, Supplementary Appendix).

A total of 446 participants experienced at least one episode of PCR- or lateral flow test-confirmed COVID-19 during 2,613,921 person-days of follow-up, of whom 32 were hospitalised. We calculated crude and minimally-adjusted ORs for associations between risk of test-confirmed COVID-19 and socio-demographic, occupational and lifestyle factors (Table 2); longstanding conditions, medication use and vaccination status (Table 3); and dietary pattern and supplemental micronutrient intake (Table 4). After adjustment for age, sex, duration of participation and testing frequency (‘minimal adjustment’), the following factors were found to associate with increased risk of COVID-19 with P <0.10: Asian / Asian British vs. White ethnic origin, housing type (paying mortgage and ‘other’ vs. owning own home), frontline vs. non-frontline worker status, household overcrowding (>0.5 vs. ≤0.5 people per bedroom), any visit vs. no visits to/from other households in the previous week, presence vs. absence of schoolchildren and working-age adults in the household, living with others vs. living alone, having vs. not having a dog at home, any vs. no travel to work or place of study in the week preceding questionnaire completion, number of visits to shops or other indoor public places per week (quartiles 2,3,4 vs quartile 1), alcohol consumption (15-21 vs 0 U/week); sleep duration (7 or 9 vs 8 hours per night); raised BMI (>25.0 vs ≤25.0 kg/m²) and history vs. no history of BCG vaccination. The following factors associated with decreased risk of COVID-19 with P<0.10 after minimal adjustment: age ≥60 vs. 16-29.99 years, education to college or postgraduate level vs primary / secondary level, lower vs. higher deprivation (IMD quartiles 2 and 3 vs 1), shielding vs. non-shielding, low-impact physical activity (≥2 vs 0 hours/week), presence vs. absence of asthma diagnosis, presence vs. absence of atopic disease (defined by atopic eczema/dermatitis and/or hayfever/allergic rhinitis), use vs. no use of systemic immunosuppressants, inhaled corticosteroids and bronchodilators (defined as β-2-adrenoreceptor agonists or anticholinergics), higher intake of fruit and vegetables (Q4 vs Q1) and use vs. no use of vitamin D supplements.

All factors associating with test-confirmed COVID-19 with P <0.10 in the minimally-adjusted model were then assessed for collinearity: the resultant heat-map (Figure S3, Supplementary Appendix) revealed a high degree of collinearity between the number of working-age adults in the household, multi-generational households and number of people per bedroom. Since household over-crowding (as indicated by number of people per bedroom) was deemed to relate most closely to SARS-CoV-2 exposure risk, the other two independent variables were excluded from the multivariable model.

Table 5 presents fully-adjusted ORs for associations between potential risk factors for test-confirmed COVID-19. The final multivariable model adjusted mutually for age, sex, duration of participation, test frequency, ethnicity, highest educational level attained, IMD rank, household income, housing type, number of people per bedroom, presence of schoolchildren at home, presence of a dog in the household, shielding, visits to/from other households, visits to shops and other indoor places, travel to work or study, frontline worker status, low-impact physical activity, alcohol intake, body mass index (BMI), history of asthma, history of atopic disease, use of systemic immunosuppressants, use of inhaled corticosteroids, use of bronchodilators, BCG vaccination status, intake of fruit, vegetables and salads, and intake of supplemental vitamin D. Increased risk of developing COVID-19 was independently associated with Asian/Asian British vs. White ethnicity (aOR 2.31, 95% CI 1.35-3.95), household overcrowding (aOR per additional 0.5 people/bedroom 1.26, 1.11-1.43), any vs. no visits to/from other households in previous week (aOR 1.33, 1.07-1.64), number of visits to indoor public places (aOR per extra visit per week 1.05, 1.01-1.09), frontline occupation outside health/social care vs. no frontline occupation (aOR 1.49, 1.12-1.98), and raised body mass index (BMI) (aOR 1.51 [1.20-1.90] for BMI 25.0-30.0 kg/m² and 1.38 [1.05-1.82] for BMI >30.0 kg/m² vs. BMI <25.0 kg/m²). Decreased risk of test-confirmed COVID-19 was independently associated with history of atopic disease (aOR 0.76, 0.59 to 0.98) and taking systemic immunosuppressants (aOR 0.43, 0.19 to 0.95).

We performed two sensitivity analyses to explore the robustness of the multivariable results. The first (Table S3, Supplementary Appendix) excluded 3202 participants who received one or more doses of COVID-19 vaccine before the date of the study download (5^th February 2021). The second (Table S4, Supplementary Appendix) excluded 3813 participants who commenced vitamin D supplements after enrolment in the cohort due to participation in a clinical trial. Both analyses yielded similar findings to those presented above.

We also performed an exploratory analysis to determine whether COVID-19 risk differed for participants with atopic vs. non-atopic asthma endotypes, as defined by the presence or absence of ‘atopic disease’ (atopic eczema/dermatitis and/or hayfever/allergic rhinitis). This showed a reduced risk of COVID-19 for participants with atopic asthma (aOR 0.64, 0.42 to 0.96), but not for those with non-atopic asthma (aOR 0.91, 0.62 to 1.33), as compared to participants without atopic disease or asthma (Table S5, Supplementary Appendix).

We then proceeded to investigate determinants of symptom-defined probable COVID-19, with casehood ascribed using an algorithm published by Menni et al.¹² In the subset of COVIDENCE UK participants who had one or more tests for COVID-19, this case definition had sensitivity and specificity for test-confirmed COVID-19 of 0.68 and 0.78, respectively, with an area under the receiver operating characteristic curve of 0.79 (95% CI, 0.76 to 0.82). Potential risk factors associating with probable symptom-defined COVID-19 with P<0.10 in a minimally-adjusted model (i.e. adjusting for age, sex and duration of participation) were included in the multivariable model presented in Table S6, Supplementary Appendix. Increased risk of probable symptom-defined COVID-19 was independently associated with Asian / Asian British vs. White ethnicity, housing type (having a mortgage vs. home-ownership), household overcrowding (>0.5 vs. ≤0.5 people per bedroom), frontline occupation outside of health or social care, use of cod liver oil supplements, poorer self-assessed general health and use of selective serotonin reuptake inhibitors, while decreased risk of probable symptom-defined COVID-19 was independently associated with greater age (age ≥50 vs. 16-29.99 years).

Discussion

In this large, prospective population-based study evaluating a diverse array of potential risk factors for developing COVID-19, we found that Asian/Asian British ethnicity, household overcrowding, indoor social mixing, employment as a frontline worker outside of health and social care, and being overweight or obese were all independently associated with an increased risk of test-confirmed COVID-19. Associations with household overcrowding and visits to indoor public places showed dose-response relationships, supporting a causal interpretation. History of atopic disease and use of systemic immunosuppressant medication were independently associated with decreased risk of test-positive disease. No statistically significant independent associations with disease risk were seen for other factors investigated, including age, sex, diet, supplemental micronutrient intake, and other longstanding conditions and medications.

This study sheds new light on the degree of overlap between risk factors for developing COVID-19 (irrespective of severity) vs. risk factors for developing severe or fatal disease specifically. Our finding that people of Asian/Asian British ethnic origin are at increased risk of developing COVID-19 is consistent with reports of increased susceptibility and disease severity in this group.^4,7,16 One limitation of previous studies investigating ethnic variation in COVID-19 risk is that they did not adjust for behaviours influencing SARS-CoV-2 exposure, such as visits to other households and indoor public places. In our study, increased risk of developing COVID-19 in people of Asian/Asian British ethnic origin was not explained by such behaviours, nor by social deprivation, domestic overcrowding, occupation, BMI, or comorbidities. There is therefore an urgent need to explain ethnic disparities in risk of developing COVID-19 so that preventive strategies can be deployed. The association between raised BMI and increased susceptibility to COVID-19 that we found is consistent with studies identifying obesity as a risk factor for both susceptibility to, and severe outcomes of, COVID-19.^4,17,18 It would appear that immune dysregulation associated with obesity may increase susceptibility to infection as well as disease severity.

By contrast, a number of established risk factors for severe and fatal disease, including older age, male sex and underlying conditions such as diabetes, heart disease, COPD and hypertension, were not associated with risk of developing COVID-19 in our study. In keeping with reports from the UK⁷ and elsewhere,⁸ we found younger age to be associated with increased risk of developing COVID-19 in crude and minimally-adjusted models. However, this association did not persist after adjustment for multiple potential confounders, including behaviours related to social mixing, suggesting that lower incidence of COVID-19 in older adults in our study may be explained by reductions in social contact. We did not see a difference in disease risk for people with diabetes, heart disease or hypertension. Whilst this contrasts with a study reporting lower prevalence of SARS-CoV-2 seropositivity among people with these underlying conditions, that study did not adjust, as we did, for behaviours influencing exposure to infection.⁷ The only long-standing conditions associated with disease risk in our study were atopic diseases, which were associated with reduced risk of disease, particularly among those who also had asthma. This may reflect decreased expression of ACE2, the SARS-CoV-2 receptor, which has been reported in people with both high levels of allergic sensitisation and asthma.¹⁹

Our study has several strengths. COVIDENCE UK was set up with the specific purpose of investigating incident COVID-19, and consequently our questionnaires were specifically designed to capture contemporaneous and granular detail on potential risk factors, including behaviours influencing risk of exposure to SARS-CoV-2. Our finding that visits to other households and indoor public places were associated with increased risk of disease supports the case for restricting such activities as a public health strategy to control disease. Our low rates of loss to follow-up reflect the very high degree of participant engagement with the COVIDENCE UK study. Our ability to identify episodes of milder disease affords potential insights into susceptibility factors as well as severity factors, and sets our study apart from long-established cohort studies in which assessment of risk factors may be temporally remote, and capture of outcomes is limited to events that are fatal or that precipitate hospitalisation. Our prospective design, coupled with censoring events occurring within 30 days of enrolment minimises the potential for reverse causation to explain associations observed.

Our study also has limitations. Use of test-confirmed COVID-19 as our primary outcome may have resulted in under-ascertainment of disease, particularly early in the pandemic (when testing capacity was particularly limited) and among people with less access to testing services; this might introduce collider bias.¹³ We addressed this limitation by including a secondary outcome of symptom-defined probable COVID-19, which did not rely on access to testing. A second issue relates to under-representation of ethnic minorities, particularly people of Black, African and Caribbean ethnic origin; a lack of statistical power may explain why we did not confirm an increased risk of disease in these groups. Third, as with any observational study, we cannot exclude the possibility that the associations we report may be explained by residual and/or unmeasured confounding. We have sought to minimise this by comprehensive capture of, and rigorous adjustment for, multiple potential confounders of relationships between putative risk factors and our primary outcome.

In conclusion, this population-based longitudinal study conducted in UK adults found that increased risk of developing COVID-19 associated independently with Asian/Asian British ethnicity, household overcrowding, visits to other households and other indoor public places, frontline occupation outside of health or social care, and increased BMI, after rigorous adjustment for multiple confounders. Atopic diseases, and especially atopic asthma, were associated with decreased risk. In contrast to studies investigating risk factors for severe disease, older age, male sex and other comorbidities were not associated with increased risk of developing COVID-19.

Author Contributions

ARM wrote the study protocol, with input from HH, MT, CR, GB and SOS. HH, MT, JS, CR, KY, MD, KT, SF, SI, AM, PP, DM, GD, RL, CJG, FK, AS, GB, SAS and ARM contributed to questionnaire development and design. HH co-ordinated and managed the study, with input from ARM, MT, JS and SOS. HH, JS, ARM, SOS, NSH and BA supported recruitment. HH, MT, MG, MD, KT, SSR, AAK, SER, PJL and DAJ contributed to data management and coding medication data. Statistical analyses were done by MT, with input from SOS, ARM, MG and HH. ARM wrote the first draft of the report. All authors revised it critically for important intellectual content, gave final approval of the version to be published, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work were appropriately investigated and resolved.

Competing Interests

All authors have completed the ICMJE uniform disclosure form. No author has had any financial relationship with any organisations that might have an interest in the submitted work in the previous three years. No author has had any other relationship, or undertaken any activity, that could appear to have influenced the submitted work.

Transparency Declaration

ARM is the manuscript’s guarantor and he affirms that this is an honest, accurate, and transparent account of the study.